<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="427">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04383652</url>
  </required_header>
  <id_info>
    <org_study_id>VISP2005</org_study_id>
    <nct_id>NCT04383652</nct_id>
  </id_info>
  <brief_title>Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales</brief_title>
  <acronym>COSiN</acronym>
  <official_title>Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kirby Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kirby Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to characterise immune responses in people with CoV-SARS-2
      infection and use this knowledge to advance vaccine design, treatment options, and diagnostic
      reagents. Eligible participants will include people diagnosed with SARS-CoV-2 infection, and
      may include recently returned travellers and non-travellers in the community presenting to
      tertiary hospital healthcare facilities. Recruitment will be opportunistic, and sampling
      intensity may vary depending on the phase of the outbreak. Participants can be enrolled at
      any timepoint (up to 6 months) following diagnosis of SARS-CoV-2 infection (COVID-19). Blood
      samples and clinical data will be collected.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 6, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Coronavirus sequencing</measure>
    <time_frame>4 months post COVID-19 diagnosis.</time_frame>
    <description>The viruses will be sequenced to to help understand epitope specificity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Coronavirus culturing</measure>
    <time_frame>4 months post COVID-19 diagnosis.</time_frame>
    <description>The viruses will then be either cultured to study the immune response against them in culture.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>COVID</condition>
  <arm_group>
    <arm_group_label>Adult cohort</arm_group_label>
    <description>Diagnosed with SARS-CoV-2 infection (COVID-19; by a registered diagnostic facility)
Age 16 years or older
Have provided informed consent
Blood samples and clinical data related to COVID19 diagnosis, symptoms, and outcomes will be collected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paediatric cohort</arm_group_label>
    <description>Diagnosed with SARS-CoV-2 infection (COVID-19; by a registered diagnostic facility)
Age less than 16 years
Parent or caregiver has provided informed consent Blood samples and clinical data related to COVID19 diagnosis, symptoms, and outcomes will be collected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biological sample and clinical data collection</intervention_name>
    <description>Plasma and serum will be collected at day 0, day 7, day 14, 1 month and 4 months post diagnosis. Clinical data related to COVID-19 diagnosis, symptoms, and outcomes will be collected.</description>
    <arm_group_label>Adult cohort</arm_group_label>
    <arm_group_label>Paediatric cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be adults, adolescents or children diagnosed with COVID-19 and attending
        a major teaching hospital located in Sydney, New South Wales Australia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Main cohort

               1. Diagnosed with CoV-SARS-2 infection

               2. 16 years of age or older

               3. Have provided informed consent Paediatric cohort

               1. Diagnosed with CoV-SARS-2 infection

               2. Less than 16 years of age

               3. Informed consent provided by parent or caregiver

                  Exclusion Criteria:

                  Main cohort

               1. 15 years of age or younger

               2. Inability or unwillingness to provide informed consent or abide by the
                  requirements of the study Paediatric cohort

               1. 16 years of age or older

               2. Inability or unwillingness of parent or caregiver to provide informed consent or
                  abide by the requirements of the study -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Marianne Martinello</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kirby Institute, UNSW Sydney</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rowena Bull</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Medical Sciences, UNSW Sydney</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rowena Bull</last_name>
    <phone>0293850900</phone>
    <email>r.bull@unsw.edu.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marianne Martinello</last_name>
    <phone>0293850900</phone>
    <email>mmartinello@Kirby.unsw.edu.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NSW Health Pathology</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Rawlinson</last_name>
      <phone>0293861214</phone>
      <email>w.rawlinson@unsw.edu.au</email>
    </contact>
    <investigator>
      <last_name>William Rawlinson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Post</last_name>
      <email>Jeffrey.Post@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Post</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sydney Children's Hospital</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adam Bartlett</last_name>
      <email>abartlett@kirby.unsw.edu.au</email>
    </contact>
    <investigator>
      <last_name>Adam Bartlett</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Blacktown Hospital</name>
      <address>
        <city>Blacktown</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Martinello</last_name>
      <email>mmartinello@Kirby.unsw.edu.au</email>
    </contact>
    <investigator>
      <last_name>Marianne Martiello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Pinto</last_name>
      <email>angie.pinto@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Angie Pinto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Darlinghurst</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gail Matthews</last_name>
      <email>gmatthews@Kirby.unsw.edu.au</email>
    </contact>
    <investigator>
      <last_name>Gail Matthews</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern Beaches Hospital</name>
      <address>
        <city>Frenchs Forest</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Mina</last_name>
      <email>michaelmina2001@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Michael Mina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>Saint Leonards</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard Hudson</last_name>
      <email>Bernard.Hudson@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Bernard Hudson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicky Gilroy</last_name>
      <email>Nicky.Gilroy@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Nicky Gilroy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 7, 2020</study_first_submitted>
  <study_first_submitted_qc>May 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 8, 2020</last_update_submitted>
  <last_update_submitted_qc>May 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Access to samples and data is governed by the Protocol Steering Committee. Requests can be made to the Committee (via the Principal Investigators).</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

